OSAM
VNDA icon

O'Shaughnessy Asset Management’s Vanda Pharmaceuticals VNDA Stock Holding History

O'Shaughnessy Asset Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-6,387
Closed -$90K – 1261
2019
Q2 		$90K Hold
6,387
– – ﹤0.01% 667
2019
Q1 		$117K Buy
+6,387
New +$146K ﹤0.01% 623
2017
Q3 		– Sell
-2,844
Closed -$46K – 997
2017
Q2 		$46K Sell
2,844
-1,377
-33% -$19.8K ﹤0.01% 722
2017
Q1 		$59K Sell
4,221
-3,650
-46% -$52K ﹤0.01% 684
2016
Q4 		$126K Sell
7,871
-308
-4% -$4.95K ﹤0.01% 602
2016
Q3 		$136K Buy
+8,179
New +$110K ﹤0.01% 563

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

O'Shaughnessy Asset Management's VNDA Position: Q3 2019 in Review

O'Shaughnessy Asset Management sold out of Vanda Pharmaceuticals (VNDA) in Q3 2019, closing a stake of 6,387 shares — an estimated $90K sold.

O'Shaughnessy Asset Management first reported a position in VNDA in Q3 2016 and held it in 6 quarters. The position peaked at $136K in Q3 2016. 168 funds tracked by Wall St. Rank hold VNDA as of Q3 2019.

  • O'Shaughnessy Asset Management reported no remaining Vanda Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 6,387 Vanda Pharmaceuticals shares in Q3 2019, an estimated $90K.
  • O'Shaughnessy Asset Management first reported a position in Vanda Pharmaceuticals in Q3 2016 and held it in 6 quarters.
  • O'Shaughnessy Asset Management's Vanda Pharmaceuticals position peaked at $136K in Q3 2016.
  • 168 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2019.

Based on O'Shaughnessy Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.